Description
Dietary supplement based on bromelain from Bromelami Retard, devil's claw and boswellia. Flebase includes in its formulation an exclusive microencapsulated and gastroprotected 2,500 GDU bromelain (Bromelami Retard) to achieve better tolerability with high bioavailability and a prolonged effect.
Suitable for vegans.

Ingredients
Devil's claw powder (Harpagophytum procumbens D.C., radix); gastroprotected bromelain: Bromelami Retard [bromelain 2,500 GDU from Ananas comosus (L.) Merr., stipites, coating agents (sucrose, corn starch, talc, shellac, hydroxypropylcellulose, maltodextrins)]; Boswellin Super: patented extract of boswellia (Boswellia serrata Roxb., gummi-resina) titrated to 50% in boswellic acids and 30% in AKBA, bulking agent (microcrystalline cellulose), anti-caking agents (silicon dioxide and magnesium stearate).
Gluten-free and lactose-free.

Nutritional characteristics

Average values	per 1 tablet
Bromelami Retard from pineapple Bromelain 2,500 GDU	500 mg 120 mg
Devil's claw	550 mg
Boswellin Super: dry extract of boswellia Boswellic acids 50% AKBA* 30%	120 mg 60 mg 36 mg

*AKBA acetyl-11-keto-beta-boswellic acid

Directions for use
Take 1 tablet 3 times a day, preferably away from meals.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Food supplements should not be intended as a substitute for a varied and balanced diet and a healthy lifestyle.

Storage
Store in a cool, dry place away from light.
Shelf life with intact packaging: 24 months.

Format
60 tablets.
Net weight: 27 g.

Code. SA.CPR.FLEBAS